Vigil Neuroscience, Inc.
VIGL · NASDAQ
6/30/2025 | 3/31/2025 | 12/31/2024 | 9/30/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $41 | $52 | $39 | $45 |
| Short-Term Investments | $26 | $35 | $59 | $66 |
| Receivables | $1 | $0 | $1 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $3 | $3 | $2 | $2 |
| Total Curr. Assets | $70 | $90 | $101 | $114 |
| Property Plant & Equip (Net) | $15 | $16 | $16 | $17 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $1 | $1 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $1 | $1 | $0 | $0 |
| Total NC Assets | $16 | $17 | $17 | $18 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $87 | $107 | $118 | $131 |
| Liabilities | – | – | – | – |
| Payables | $2 | $3 | $2 | $1 |
| Short-Term Debt | $2 | $1 | $1 | $1 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $20 | $20 | $0 |
| Other Curr. Liab. | $30 | $7 | $11 | $29 |
| Total Curr. Liab. | $34 | $30 | $34 | $31 |
| LT Debt | $11 | $12 | $12 | $12 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $11 | $12 | $12 | $12 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $12 | $13 | $13 | $13 |
| Total Liabilities | $45 | $42 | $46 | $43 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$356 | -$329 | -$307 | -$283 |
| AOCI | $0 | $0 | $0 | $0 |
| Other Equity | $397 | $395 | $379 | $372 |
| Total Equity | $41 | $65 | $72 | $89 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $87 | $107 | $118 | $131 |
| Net Debt | -$28 | -$39 | -$26 | -$32 |